LIXT

Bearish

Lixte Biotechnology stock falls after $16.6M capital raise By Investing.com

Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) saw its shares drop by 3.4% following the announcement of a $16.6 million registered direct offering. ...

Investing.com Nigeria 2 weeks ago 0

Bullish

Lixte shifts from cancer drugs to AI energy infrastructure

Lixte Biotechnology Holdings, Inc. is transitioning from a pharmaceutical company into an AI energy infrastructure equipment and services platform, ap...

Investing.com 2 weeks ago 0